AAN guideline: Plasma exchange effective in treating severe MS relapses, neuropathies

Jan 17, 2011

A new guideline from the American Academy of Neurology recommends using plasma exchange to treat people with severe relapses in multiple sclerosis (MS) and related diseases, as well as those with certain kinds of nerve disorders known as neuropathies. The guideline is published in the January 18, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

Plasma exchange, formally known as plasmapheresis, is the process of taking blood out of the body, removing constituents in the blood's plasma thought to be harmful, and then transfusing the rest of the blood (mainly ) mixed with replacement plasma back into the body.

The guideline recommends doctors consider using plasma exchange as a secondary treatment for severe flares in relapsing forms of MS and related diseases. The treatment was not found to be effective for secondary progressive and chronic progressive forms of MS.

According to the guideline, doctors should offer plasma exchange for treatment of severe forms of Guillain-Barré syndrome and for temporary treatment of chronic inflammatory demyelinating polyneuropathy. Plasma exchange may also be considered for treatment of some other kinds of inflammatory neuropathies.

"These types of neurologic disorders occur when the body's immune system mistakenly causes damage to the nervous system. Plasma exchange helps because it removes factors in the plasma thought to play a role in these disorders," said guideline lead author Irene Cortese, MD, a neurologist with the National Institutes of Health in Bethesda, Md., and a member of the American Academy of Neurology.

The guideline authors also looked at the use of plasma exchange for other neurologic disorders, including myasthenia gravis and pediatric autoimmune neuropsychiatric disorders (PANDAS), but there was not enough evidence to determine whether it is an effective treatment.

Side effects of plasma exchange include infection and blood-clotting issues.

Explore further: Controlling Ebola in West Africa most effective way to decrease international risk

add to favorites email to friend print save as pdf

Related Stories

AAN guideline evaluates treatments for muscle cramps

Feb 22, 2010

A new guideline from the American Academy of Neurology recommends that the drug quinine, although effective, should be avoided for treatment of routine muscle cramps due to uncommon but serious side effects. The guideline ...

Panasonic to show TV at Stock Exchange

Apr 18, 2006

Panasonic will be showcasing the world's largest high-definition plasma television at the closing bell of the New York Stock Exchange Tuesday.

Recommended for you

WHO: Ebola vaccine trials in W. Africa in January

34 minutes ago

Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe, a top World Health Organization official ...

Ebola cases rise sharply in western Sierra Leone

44 minutes ago

After emerging months ago in eastern Sierra Leone, Ebola is now hitting the western edges of the country where the capital is located with dozens of people falling sick each day, the government said Tuesday. So many people ...

US orders new screening for Ebola

1 hour ago

Everyone coming to the United States from the three West African countries at the center of the Ebola outbreak will now be screened for the deadly disease at one of five airports, the Homeland Security Department said Tuesday.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

ormondotvos
not rated yet Jan 18, 2011
And severe shingles?